Mikrobiol. Z. 2019; 81(6):69-82. Ukrainian.
doi: https://doi.org/10.15407/microbiolj81.06.069

Immunomodulatory Effect of Probiotic Strain Lactobacillus casei IMV B-7280
on Physiological Norm in Experimental Animals

Lazarenko L.M., Babenko L.P., Spivak M.Ya.

Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
154 Akad. Zabolotny Str., Kyiv, 03143, Ukraine

The aim of this work was to determine the immunomodulatory effect of the Lactobacillus casei B-7280 strain in the physiological norm by studying its effect on the functional activity of cells of the phagocytic system, the phenotypic composition of spleen lymphocytes and the level of pro- and anti-inflammatory cytokines in the blood serum of experimental animals. Methods. The B-7280 strain was administered to intact immunodeficient BALB/c mice orally using a probe or vaginally. Absorption activity, as well as oxygen-dependent bactericidal activity of macrophages of peritoneal exudate (MFPE) was assessed using common research methods. The number of CD16+/56+ natural killer cells (NKC), CD3+ T-lymphocytes, CD4+ T-helpers/inductors, CD8+ T-supressors/cytotoxic and CD19+ B-lymphocytes was determined in the spleen using the method of flow cytometry. The levels of pro- (interleukin (IL)-12 and interferon (IFN)-γ) and anti-inflammatory (IL-4) cytokines in serum were determined by enzyme immunoassay. Results. It was found that the B-7280 strain activated the phagocytic mechanisms of immune reactivity at the physiological norm: the number of MFPEs capable for absorbing the object of phagocytosis increased, the intensity of their absorbing function and digestive capacity increased and the level of functional reserve remained normal. The levels of IL-12 and IFN-γ in blood serum were increased in mice that received this strain both orally or vaginally, against the background of decrease or tendency to decrease the level of serum IL-4 in different terms of observation, which indicates its potential ability to induce the development of the immunity cellular link. At the physiological norm, the B-7280 strain did not influence the amount of NKC in the spleen and such important parameters of cellular and humoral factors of acquired immunity as the phenotypic composition of spleen lymphocytes. Activation of phagocytes and changes in the level of cytokines in mice’ blood serum after the use of strain B-7280 was not accompanied by deterioration of their physical condition or any form of intoxication. Conclusions. The B-7280 strain has immunomodulatory properties at the physiological norm aimed at activation of congenital immune factors and balancing the production of Th1/Th2 cytokines. The strain is promising for the development of probiotics (immunobiotics) with immunomodulatory properties, which can be used for the prevention and treatment of infectious and other diseases. The expediency of further studies of its biological activity and safety in different experimental models, as well as in clinical studies, has been substantiated.

Keywords: Lactobacillus, immune system, cytokines, physiological norm, experimental animals.

Full text (PDF, in Ukrainian)

  1. Shirobokov VP, Yankovskiy DS, Dyiment GS. [Mikrobnaya ekologiya cheloveka s tsvetnyim atlasom. Uchebnoe posobie]. Kyiv: Chervona Ruta-Turs, 2010. Russian.
  2. Williams NT. Probiotics. Am J Health Syst Pharm. 2010; 67(6):449–58. https://doi.org/10.2146/ajhp090168
  3. Lebeer S, Bron PA, Marco ML, Van Pijkeren JP, O’Connell Motherway M, et al. Identification of probiotic effector molecules: present state and future perspectives. Curr Opin Biotechnol. 2018; 49:217–23. https://doi.org/10.1016/j.copbio.2017.10.007
  4. Yadav R, Singh PK, Shukla P. Metabolic engineering for probiotics and their genomewide expression profiling. Curr Protein Pept Sci. 2018; 19(1):68–74. https://doi.org/10.2174/1389203718666161111130157
  5. Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018; 174(6):1388–1405. https://doi.org/10.1016/j.cell.2018.08.041
  6. Nichols RG, Peters JM, Patterson AD. Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Hum Genomics. 2019; 13(1):27. https://doi.org/10.1186/s40246-019-0211-9
  7. Arena MP, Capozzi V, Russo P, Drider D, Spano G, Fiocco D. Immunobiosis and probiosis: antimicrobial activity of lactic acid bacteria with a focus on their antiviral and antifungal properties. Appl Microbiol Biotechnol. 2018; 102(23):9949–58. https://doi.org/10.1007/s00253-018-9403-9
  8. Halloran K, Underwood MA. Probiotic mechanisms of action. Early Hum Dev. 2019; S0378-3782(19):30294–4.
  9. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003; 8(3):223–46.
  10. Abedin-Do A, Taherian-Esfahani Z, Ghafouri-Fard S, Ghafouri-Fard S, Motevaseli E. Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells. Immunotherapy. 2015; 7(12):1307–29. https://doi.org/10.2217/imt.15.92
  11. Rø ADB, Simpson MR, Rø TB, Storrø O, Johnsen R, Videm V, et al. Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation. Clin Exp Allergy. 2017; 47(8):1014–21. https://doi.org/10.1111/cea.12930
  12. Azad MAK, Sarker M, Wan D. Immunomodulatory effects of probiotics on cytokine profiles. Biomed Res Int. 2018; 2018:8063–647. https://doi.org/10.1155/2018/8063647
  13. Marteau Philippe. Safety aspects of probiotic products. Scan J Nutr/Naringsforskning. 2001; 45:22–242. https://doi.org/10.3402/fnr.v45i0.1785
  14. Guidelines for the Evaluation of Probiotics. Food Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food London Ontario, Canada April 30 and May 1, 2002.
  15. Shanahan F. A commentary on the safety of probiotics. Gastroenterol Clin North Am. 2012; 41(4):869–76. https://doi.org/10.1016/j.gtc.2012.08.006
  16. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015; 60 Suppl 2:S129–34. https://doi.org/10.1093/cid/civ085
  17. Falalyeyeva TM, Leschenko IV, Beregova TV, Lazarenko LM, Savchuk OM, Sichel LM, et al. Probiotic strains of lactobacilli and bifidobacteria alter pro- and antiinflammatory cytokines production in rats with monosodium glutamate-induced obesity. Fiziol Zh. 2017; 63(1):17–25. https://doi.org/10.15407/fz63.01.017
  18. Lazarenko LM, Babenko LP, Mokrozub VV, Demchenko OM, Bila VV, Spivak M.Ya. Effects of oral and vaginal administration of probiotic bacteria on the vaginal microbiota and cytokines production in the case of experimental Staphylococcosis in mice. Mikrobiol. Z. 2017; 79(6):105–19. https://doi.org/10.15407/microbiolj79.06.105
  19. Drannik G.N. [Klinicheskaya immunologiya i allergologiya]. Kiev:OOO Poligraf plyus, 2010. Russian.
  20. Reznikov O. [Problemi etiki pri provedenni eksperimentalnih medichnih i biologichnih doslidzhen na tvarinah]. Visnik NANU. 2001; 1:5–7. Ukrainian.
  21. [Laboratornyie zhivotnyie: razvedenie, soderzhanie, ispolzovanie v eksperimente]. Pod red. IP Zapadnyuka. Kyiv: Vischa shkola, 1983. Russian.
  22. [Sovremennyie metodyi diagnostiki virusnyih respiratornyih infektsiy i ih terapii s ispolzovaniem preparatov interferona (Metodicheskie rekomendatsii)]. Pod. red. Modzolevskogo AF, Dyachenko NS, Spivaka NYa. Kyiv, 1994. Russian.
  23. Beyli N. [Statisticheskie metodyi v biologii]. Moscow: Izd-vo inostrannoy literaturyi, 1962. Russian.
  24. Simbirtsev AS, Totolyan AA. [Tsitokinyi v laboratornoy diagnostike. Klinicheskaya laboratornaya diagnostika: Natsionalnoe rukovodstvo], pod red. Dolgova VV, Menshikova VV. Moskva: GEOTAR-Media, 2013; 193–217. Russian.
  25. Savcheniuk OA, Virchenko OV, Falalyeyeva TM, Beregova TV, Babenko LP, Lazarenko LM, et al. The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention. EPMA J. 2014; 5(1):2. https://doi.org/10.1186/1878-5085-5-2
  26. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci. 1998; 81(1):48–53. https://doi.org/10.3168/jds.S0022-0302(98)75549-3
  27. De Petrino SF, Bibas Bonet ME, Mesón O, Perdigón G. The effect of Lactobacillus casei on an experimental model of atopy. Food Agric Immunol. 2002; 14(3):181–9. https://doi.org/10.1080/09540100220145000c
  28. Yasui H, Kiyoshima J, Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol. 2004; 11(4):675–9. https://doi.org/10.1128/CDLI.11.4.675-679.2004
  29. Haro C, Villena J, Zelaya H, Alvarez S, Agüero G. Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model. J Inflamm (Lond). 2009; 6:28. https://doi.org/10.1186/1476-9255-6-28
  30. Fayyaz I, Zahoor MA, Shahid M, Rasool MH, Nawaz Z. Effect of Lactobacillus casei on serum interleukins following enteropathogenic E. coli infection in experimental rabbits. Pak J Pharm Sci. 2018;31(5):2131–36.
  31. Huang L, Chiang Chiau JS, Cheng ML, Chan WT, Jiang CB, Chang SW, et al. SCID/ NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy. Pediatr Neonatol. 2019; 60(3):252–60. https://doi.org/10.1016/j.pedneo.2018.07.007
  32. Zarfeshani A, Khaza’ai H, Mohd Ali R, Hambali Z, Wahle KW, Mutalib MS. Effect of Lactobacillus casei on the production of pro-inflammatory markers in streptozotocininduced diabetic rats. Probiotics Antimicrob Proteins. 2011; 3(3–4):168–74. https://doi.org/10.1007/s12602-011-9080-9
  33. Manirarora JN, Parnell SA, Hu YH, Kosiewicz MM, Alard P. NOD dendritic cells stimulated with lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidence. Clin Dev Immunol. 2011; 2011:6301–87. https://doi.org/10.1155/2011/630187
  34. Soltan Dallal MM, Yazdi MH, Holakuyee M, Hassan ZM, Abolhassani M, Mahdavi M. Lactobacillus casei ssp. casei induced Th1 cytokine profile and natural killer cells activity in invasive ductal carcinoma bearing mice. Iran J Allergy Asthma Immunol. 2012; 11(2):183–9.
  35. Zhang L, Li N, Caicedo R, Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005; 135(7):1752–6. https://doi.org/10.1093/jn/135.7.1752